R Eastell
Overview
Explore the profile of R Eastell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
7925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cummings S, Eastell R
Osteoporos Int
. 2020 Mar;
31(6):1023-1024.
PMID: 32173783
No abstract available.
12.
Paggiosi M, Debono M, Walsh J, Peel N, Eastell R
Osteoporos Int
. 2020 Jan;
31(4):667-675.
PMID: 31993717
Introduction: We evaluated the ability of lumbar spine bone mineral apparent density (BMAD), trabecular bone score (TBS) and volumetric bone mineral density (vBMD) to discriminate between postmenopausal women with low...
13.
Vasikaran S, Bhattoa H, Eastell R, Heijboer A, Jorgensen N, Makris K, et al.
Osteoporos Int
. 2020 Jan;
31(3):409-412.
PMID: 31975180
Introduction: In order to examine the agreement between current commercial assays, a multi-center study was performed for PINP in serum and plasma. Methods: The automated methods for PINP (Roche Cobas...
14.
Gossiel F, Paggiosi M, Naylor K, McCloskey E, Walsh J, Peel N, et al.
Bone
. 2019 Nov;
131:115158.
PMID: 31740343
Postmenopausal osteoporosis is characterised by increased bone turnover and an imbalance between bone resorption and formation. Bisphosphonate treatment reduces bone turnover but their effect on bone balance is yet to...
15.
Cacciottolo T, Perikari A, van der Klaauw A, Henning E, Stadler L, Keogh J, et al.
QJM
. 2019 Sep;
112(9):724-729.
PMID: 31505685
No abstract available.
16.
Eastell R, Mitlak B, Wang Y, Hu M, Fitzpatrick L, Black D
Osteoporos Int
. 2019 Jan;
30(3):667-673.
PMID: 30635696
Introduction: We evaluated the relationship between early PINP changes and subsequent changes in spine BMD following abaloparatide and teriparatide treatments. We also explored the use of an "uncoupling index" (UI),...
17.
Naylor K, McCloskey E, Jacques R, Peel N, Paggiosi M, Gossiel F, et al.
Osteoporos Int
. 2019 Jan;
30(4):917-922.
PMID: 30613868
Introduction: Measurement of bone turnover markers (BTMs) may be useful to monitor offset of treatment with bisphosphonates (BP) in osteoporosis. We assessed the effect of withdrawal of BP treatment by...
18.
Vilaca T, Walsh J, Eastell R
Osteoporos Int
. 2018 Oct;
30(1):135-143.
PMID: 30306223
Introduction: There is evidence for an increase in the risk of hip fractures in diabetes (both in type 1 and 2), but the risk is not established for other skeletal...
19.
Ferrari S, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al.
Osteoporos Int
. 2018 Aug;
29(12):2585-2596.
PMID: 30066131
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the...
20.
Naylor K, Bradburn M, Paggiosi M, Gossiel F, Peel N, McCloskey E, et al.
Osteoporos Int
. 2018 Mar;
29(6):1407-1417.
PMID: 29525970
Introduction: Bisphosphonates (BPs) continue to suppress bone turnover markers (BTMs) after treatment has stopped, leading to the suggestion that a pause in treatment could be considered for low-risk patients. Indirect...